Victory Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $93.5K | Sell |
11,486
-50,854
| -82% | -$414K | ﹤0.01% | 2332 |
|
2025
Q1 | $489K | Buy |
62,340
+16,622
| +36% | +$130K | ﹤0.01% | 2038 |
|
2024
Q4 | $681K | Sell |
45,718
-2,764
| -6% | -$41.2K | ﹤0.01% | 1947 |
|
2024
Q3 | $741K | Sell |
48,482
-1,220
| -2% | -$18.7K | ﹤0.01% | 1894 |
|
2024
Q2 | $757K | Sell |
49,702
-25,624
| -34% | -$390K | ﹤0.01% | 1826 |
|
2024
Q1 | $1.42M | Sell |
75,326
-29,087
| -28% | -$549K | ﹤0.01% | 1573 |
|
2023
Q4 | $1.99M | Buy |
104,413
+36,312
| +53% | +$694K | ﹤0.01% | 1429 |
|
2023
Q3 | $1.22M | Sell |
68,101
-6,062
| -8% | -$109K | ﹤0.01% | 1559 |
|
2023
Q2 | $1.51M | Sell |
74,163
-19,903
| -21% | -$404K | ﹤0.01% | 1492 |
|
2023
Q1 | $1.72M | Buy |
94,066
+28,403
| +43% | +$518K | ﹤0.01% | 1453 |
|
2022
Q4 | $1.36M | Buy |
65,663
+48,003
| +272% | +$993K | ﹤0.01% | 1581 |
|
2022
Q3 | $462K | Buy |
17,660
+1,898
| +12% | +$49.7K | ﹤0.01% | 2082 |
|
2022
Q2 | $399K | Sell |
15,762
-1,469
| -9% | -$37.2K | ﹤0.01% | 2149 |
|
2022
Q1 | $417K | Buy |
17,231
+10,384
| +152% | +$251K | ﹤0.01% | 2191 |
|
2021
Q4 | $277K | Sell |
6,847
-436
| -6% | -$17.6K | ﹤0.01% | 2404 |
|
2021
Q3 | $254K | Sell |
7,283
-63,577
| -90% | -$2.22M | ﹤0.01% | 2438 |
|
2021
Q2 | $1.95M | Sell |
70,860
-1,459,488
| -95% | -$40.1M | ﹤0.01% | 1645 |
|
2021
Q1 | $43M | Buy |
1,530,348
+397,786
| +35% | +$11.2M | 0.04% | 611 |
|
2020
Q4 | $29.4M | Sell |
1,132,562
-55,997
| -5% | -$1.45M | 0.03% | 722 |
|
2020
Q3 | $20.4M | Buy |
1,188,559
+295,955
| +33% | +$5.07M | 0.03% | 791 |
|
2020
Q2 | $22.1M | Buy |
892,604
+882,912
| +9,110% | +$21.8M | 0.03% | 732 |
|
2020
Q1 | $134K | Buy |
+9,692
| New | +$134K | ﹤0.01% | 2445 |
|
2019
Q4 | – | Sell |
-4,491
| Closed | -$41K | – | 3131 |
|
2019
Q3 | $41K | Buy |
+4,491
| New | +$41K | ﹤0.01% | 2769 |
|